Omeprazole and risk of osteoarthritis: insights from a mendelian randomization study in the UK Biobank

• Published in: Journal of translational medicine 2024-05, Vol.22 (1), p.504-504, Article 504
• Main Authors: Cao, Siyang, Wei, Yihao, Yue, Yaohang, Li, Guoqing, Wang, Hongli, Lin, Jianjing, Wang, Qichang, Liu, Peng, Yu, Fei, Xiong, Ao, Zeng, Hui
• Format: Article
• Language: English
• Subjects: Biological Specimen Banks; Causal association; Complications and side effects; Dosage and administration; Female; Genetics; Humans; Male; Mendelian randomization; Mendelian Randomization Analysis; Middle Aged; Omeprazole; Omeprazole - adverse effects; Osteoarthritis; Osteoarthritis - genetics; Risk Factors; UK Biobank; United Kingdom - epidemiology
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-024-05255-y

A former cohort study has raised concern regarding the unanticipated hazard of omeprazole in expediting osteoarthritis (OA) advancement. The precise nature of their causal evidence, however, remains undetermined. The present research endeavors to investigate the underlying causal link between omeprazole and OA through the application of mendelian randomization (MR) analysis. The study incorporated the ukb-a-106 and ukb-b-14,486 datasets. The investigation of causal effects employed methodologies such as MR-Egger, Weighted median, Inverse variance weighted (IVW) with multiplicative random effects, and IVW (fixed effects). The IVW approach was predominantly considered for result interpretation. Sensitivity analysis was conducted, encompassing assessments for heterogeneity, horizontal pleiotropy, and the Leave-one-out techniques. The outcomes of the MR analysis indicated a causal relationship between omeprazole and OA, with omeprazole identified as a contributing risk factor for OA development (IVW model: OR = 1.2473, P